Advertisement

U.S. Markets open in 5 hrs 4 mins

S&P Futures
5,915.00
-5.00(-0.08%)
Dow Futures
43,463.00
-77.00(-0.18%)
Nasdaq Futures
20,618.00
-15.50(-0.08%)
Russell 2000 Futures
2,312.20
-5.50(-0.24%)
Crude Oil
68.68
-0.48(-0.69%)
Gold
2,629.30
+14.70(+0.56%)

Ainos, Inc. (AIMDW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

0.0260

-0.0290

(-52.73%)

At close: 03:00PM EST

Trade prices are not sourced from all markets

All

ACCESSWIRE
Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments
Taiwan regulatory approval for the trial expected in Q1 2025 Remains committed to a capital-efficient business strategy SAN DIEGO, CA / ACCESSWIRE / November 13, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative ...
ACCESSWIRE
Ainos Announces IRB Approval for Sjögren’s Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025
IRB approval on track as scheduled Next step is obtaining all regulatory approvals, followed by site initiation visit VELDONA significantly increases unstimulated whole salivary flow in prior Phase 3 studies SAN DIEGO, CA / ACCESSWIRE / November 11, ...
Simply Wall St.
Ainos Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.73 loss in 3Q 2023)
Ainos ( NASDAQ:AIMD ) Third Quarter 2024 Results Key Financial Results Net loss: US$3.70m (loss widened by 24% from 3Q...